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Abstract
Medicinal plants play a key role in
human health care. Pterocarpus
marsupium is one of the plants used in
treatment of diabetes mellitus and the
present study was aimed to assess
hepatoprotective effect of the plant
against CCl4 induced hepatotoxicity.
Wistar albino rats were divided into
four groups. Group I was normal
control group; Group II, the
hepatotoxic group was given CCl4
(2ml/kg body weight
intraperitoneally); Groups III received
CCl4+ Plant extract (100mg/kg b.w
orally); Group IV received only the
plant extract. Liver markers were
assayed in serum and liver tissue.
Levels of marker enzymes such as
alanine transminase (ALT), aspartate
transaminase (AST), alkaline
phosphatase (ALP), and lactate
dehydrogenase (LDH) and bilirubin
were increased significantly in Group
II. These enzymes were significantly
decreased in Group III treated with
plant extracts. The present
investigation suggest that the plant
had a good protective effect on CCl4
induced hepatic injury.
Introduction
The liver holds a unique position in the
human body because of its
gastrointestinal connections and
varied functions. Liver receives large
amount of nutrients and noxious
compounds entering the body through
the digestive tract and portal vein1. As
a result of its continuous involvement,
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it is susceptible to toxic injuries caused
by certain agents and hence any
damage to hepatic cells will disturb
body metabolism2. In spite of the
tremendous advancement in modern
medicine, there are hardly any drugs
that stimulate liver function, offer
protection to the liver from damage or
help in regeneration of hepatic cells3.
Nature has bestowed on us a very rich
botanical wealth and a large number
of diverse type of plants growing in
different parts of the country. Plants
form a major part of the therapeutic
ingredients in almost all systems of
medical sciences4.
Herbal medicines have been used since
the dawn of civilization to maintain
health and to treat diseases. Medicinal
plants commonly included in ayurvedic
recipes for liver nutrients have drawn
much attention and research
investigations induced on several
natural plant products used as liver
protectives have been well
documented5. Pterocarpus marsupium is
one of the drugs being used in the
treatment of diabetes mellitus. Hence,
the present study aimed to assess the
Anti-hepatotoxic effect of the plant
against CCl4 induced hepatotoxicity in
rats.
Materials and Method
The plant was obtained from SKM,
Sidha Pharmaceutical, Erode. The
powder form of the plant was used for
analysis. The decoction of the drug was
prepared by taking 10gm of drug
powder in 100ml of water and boiled
for 10 minutes.  The filtrate of this
solution was used for the study. The
hepatoprotective effect was assessed in
experimental rats. Male Albino rats of
Wister strain weighing 120-150gm
were selected. They were housed
under standard condition and
maintained on a standard diet and
divided into 4 groups and treatment
protocol as follows.
Group  I  :  Control rats (6no).
Group II :  Negative control – Induction
of hepatotoxicity by injecting CCl4 with
paraffin oil (1:1), 2ml/kg body weight
intraperitoneally on 2nd and 3rd day.
Group III : The drug was administered
orally for 5 days;CCl4 in paraffin oil
(1:1,2ml/kg bw) was given
intraperitoneally on 2nd and 3rd day.
Group IV : Positive control, the animal
were administered the plant decoction
orally for 5 days (100mg/kg b.w orally).
The animals were sacrificed on  6th day.
All the animal were anesthetized with
chloroform and blood was drawn and
serum was collected .The liver was
removed for histopathology and
biochemical studies. AST6, ALT6, ALP7,
LDH8 in serum and liver and bilirubin9
in serum were analyzed according to
the standard protocols.
Results And Discussion
The activity of hepatic marker enzymes
AST, ALT, ALP and LDH were assessed
in serum and liver homogenate in
different groups of rats.
From Table-1 and 2 it was very obvious
that there was a significant increase in
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AST, ALT, LDH, ALP levels in group
II (CCl4 treated) rats when compared
to the normal rats in both the serum
and liver. CCl4 induced hepatotoxicity
depends on reductive dehalogenation
of CCl4 catalyzed by Cytochrome  P450
in the liver cells endoplasmic reticulum.
It has become clear that a cascade of
secondary metabolc activities is evoked
by the initial events of CCl4 metabolism
and that the secondary mechanisms
are responsible for  ultimate plasma
membrane disruption and death of
cell10,11. The mechanisms by which toxic
metabolites are formed, include
formation of electrophiles or free
radicals, which can form covalent
adducts with cellular macro molecules,
inducing proteins, lipids and nucleic
acids, leading to disruption of their
function12. There is evidence that the
responsible metabolite is a free radical
(CCl4 and the derived peroxy radical
CCl3OO). These appear to produce
peroxidation of the unsaturated lipids
of cellular membranes and probably
convert other cellular molecules to
secondary free radicals that extend the
injury13,14,15,16. There is reason to believe
that native, nonmetabolized CCl4 also
may contribute the leakage of
intracellular enzymes, coenzymes and
electrolytes from the hepatocytes  and
entry of calcium and  other ions into
cytosol17,18
In Group III plant extracts seems to
offer protection, which was evident
from the significant reduction of all the
enzymes in serum and liver when
compared with group II. Similarly
increased level of bilirubin in group II
was noted which might be due to
destruction of erythrocytes by toxic
metabolites leading to over production
or failure to excrete bilirubin.
Administration of plant extracts in
group III decreased the elevation.
The results of the histopathological
studies of section of liver of control and
experimental rats carried out to test the
toxicity of aqueous extract of the plant
on it obtained are tabulated in table-3
and shown in figure 1.
Thus it can be concluded that CCl4
produces fatty changes and was well
brought out in these animal sections.
But on treatment with the drug the liver
showed microvascular steotosis only.
Thus the plant extract offered protection
against CCl4 and shows its
hepatoprotective effect in Albino rats
Pages 19 - 2522
T
a
b
l
e
 
1
L
e
v
e
l
s
 
o
f
 
t
h
e
 
E
n
z
y
m
e
s
 
a
n
d
 
B
i
l
i
r
u
b
i
n
 
i
n
 
s
e
r
u
m
 
o
f
 
C
o
n
t
r
o
l
 
a
n
d
 
E
x
p
e
r
i
m
e
n
t
a
l
 
g
r
o
u
p
s
 
 
 
V
a
l
u
e
s
 
a
r
e
 
e
x
p
r
e
s
s
e
d
 
b
y
 
m
e
a
n
 
±
 
S
D
 
 
 
a
 
–
 
m
g
 
p
y
r
u
v
a
t
e
 
l
i
b
e
r
a
t
e
d
 
/
1
0
0
 
m
l
 
o
f
 
s
e
r
u
m
 
a
t
 
3
7
0
C
 
 
 
b
 
-
 
m
g
 
o
f
 
p
h
e
n
o
l
 
l
i
b
e
r
a
t
e
d
 
/
1
0
0
 
m
l
 
o
f
 
s
e
r
u
m
 
a
t
 
3
7
0
C
 
 
 
c
 
-
 
m
g
 
p
y
r
u
v
a
t
e
 
l
i
b
e
r
a
t
e
d
 
/
1
0
0
 
m
l
 
o
f
 
s
e
r
u
m
 
a
t
 
3
7
0
C
 
 
 
*
 
-
 
P
(
<
0
.
0
5
)
 
S
i
g
n
i
f
i
c
a
n
t
 
w
h
e
n
 
g
r
o
u
p
 
I
I
 
c
o
m
p
a
r
e
d
 
w
i
t
h
 
g
r
o
u
p
 
I
 
 
 
#
 
-
 
P
(
<
0
.
0
5
)
 
S
i
g
n
i
f
i
c
a
n
t
 
w
h
e
n
 
g
r
o
u
p
 
I
I
I
 
c
o
m
p
a
r
e
d
 
w
i
t
h
 
g
r
o
u
p
 
I
I
 
 
 
$
 
-
 
P
(
<
0
.
0
5
)
N
o
t
 
S
i
g
n
i
f
i
c
a
n
t
 
w
h
e
n
 
g
r
o
u
p
 
I
V
 
c
o
m
p
a
r
e
d
 
w
i
t
h
 
g
r
o
u
p
 
I
Pages 19 - 2523
Table 2
Levels of the Enzymes  in Liver of  Control and Experimental groups
Values are mean± SD
a – mg pyruvate liberated /mg protein at 370C
b- mg of phenol liberated /mg protein at 370C
c - mg pyruvate liberated /mg protein at 370C
*- P(<0.05) Significant when Group II compared with group I
#- P(<0.05) Significant when Group III compared with group II
$- P(<0.05)Not Significant when Group IV compared with group I
Table  4.  Histopathlogical Observations in Control and Experimental Groups
Animal group  Histopathological examination 
Group I – Normal  Normal liver architecture 
Group II – CCl4 injected 
Lobular hepatocellular Necrosis steatosis 
and fibrosis 
Group II – CCl4 injected + plant Extract  Minimal hepato cellular necrosis 
Group II – Plant extract injected rats  Normal liver architecture 
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